Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis

Launched by CAIRO UNIVERSITY · May 20, 2017

Keywords

ClinConnect Summary

Objective: The aim of this clinical trial is to evaluate the effect of pre-operative administration of diclofenac potassium on the efficacy of inferior alveolar nerve block on using 2% mepivacaine anaesthetic agent in patients with symptomatic irreversible pulpitis.

Design: Randomized double-blind controlled trial.

Setting and conduct:

* Patients source: Out patients of the clinic of Endodontics at the Faculty of Oral and Dental Medicine, Cairo University.
* Patients will be clinically and radiographically examined and their eligibility will be assessed and preoperative pain will be meas...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients in good health as determined by a medical history and oral questioning. (ASA I or II)
• • 2. Age range is between 18 and 50 years.
• • 3. Patients having symptomatic irreversible pulpitis in one of their mandibular molars.
• • 4. Patients who can understand Heft Parker Visual Analogue Scales VAS.
• • 5. Patients accepting to participate in the study and able to sign informed consent.
• Exclusion Criteria:
• • 1. Pregnant female patient.
• • 2. Patients allergic to diclofenac potassium or mepivacaine.
• • 3. Patients having active pain in more than one mandibular molar.
• • 4. Patients who had taken analgesics in the 12 hours preceding the injection.